Latest news for CD Intl Enterprises (OTC:CDIIQ) Stock

CD International Enterprises Inc is the United States based company that sources and distributes industrial products in China and the Americas. The company also provides business and management consulting services to public and private American and Chinese businesses. It operates in two identifiable segments - Trading and Consulting. The Trading segment is engaged in sources and distribution of industrial commodities from North and South America for ultimate distribution in China. The Consulting segment provides business and management consulting services to the United States public companies that operate primarily in China.

CD INTERNATIONAL ENT INC by CD International Enterprises, Inc.

CD International Enterprises Inc

<p>Keefe, Bruyette &amp; Woods  analyst Aidan Hall   maintains Evercore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) with a Outperform and lowers the price target from $339 to $319.</p>


News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Outperform on Evercore, Lowers Price Target to $319

<p>BTIG  analyst Janine Stichter   maintains Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) with a Buy and raises the price target from $185 to $190.</p>


BOOT

BTIG Maintains Buy on Boot Barn Holdings, Raises Price Target to $190

<p>Keefe, Bruyette &amp; Woods  analyst Kyle Voigt   maintains Coinbase Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Market Perform and lowers the price target from $275 to $255.</p>


COIN

Keefe, Bruyette & Woods Maintains Market Perform on Coinbase Glb, Lowers Price Target to $255

<p>Citigroup  analyst Piyush Avasthy   maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $44 to $42.</p>


CGNX

Citigroup Maintains Neutral on Cognex, Lowers Price Target to $42

<p>Keefe, Bruyette &amp; Woods  analyst Kyle Voigt   maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and lowers the price target from $260 to $256.</p>


Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Lowers Price Target to $256

<p>Citigroup  analyst Andrew Kaplowitz   maintains Carrier Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) with a Buy and lowers the price target from $94 to $90.</p>


CARR

Citigroup Maintains Buy on Carrier Global, Lowers Price Target to $90

<p><a href="https://x.com/FuzzyPandaShort/status/1878853285098213646" title="https://x.com/FuzzyPandaShort/status/1878853285098213646">https://x.com/FuzzyPandaShort/status/1878853285098213646</a></p>


Short Sellers

Trading Ideas

AIRS

FuzzyPanda Posts On X "Ozempic has sucked all the EBITDA out of $AIRS. Mgmt just guided to $AIRS just tripped their debt covenants.  Needed to guide to EBITDA >$26.5m by our est's. Remediation for tripping debt covenants = all Airsculpt's debt is due immediately. Next stop bankruptcy?"

<p>TD Cowen  analyst Marc Bianchi   upgrades Linde (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>) from Hold to Buy and raises the price target from $480 to $515.</p>


Upgrades

TD Cowen Upgrades Linde to Buy, Raises Price Target to $515

<p>Keefe, Bruyette &amp; Woods  analyst Timothy Switzer   maintains CNB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCNE#NASDAQ">CCNE</a>) with a Market Perform and lowers the price target from $30 to $28.</p>


CCNE

Keefe, Bruyette & Woods Maintains Market Perform on CNB Financial, Lowers Price Target to $28

WIIM

Amer Sports shares are trading lower. The company announced FY24 financial results.

<p>As 2025 kicks off, investors are feeling bullish about the <a href="https://www.benzinga.com/tech">U.S. Internet sector</a>—and JPMorgan analyst Doug Anmuth's latest survey suggests optimism is running high. </p>
<p>Nearly 100 investors shared their insights, revealing a market eager for tech-driven innovation despite looming challenges.</p>
<h2 class="wp-block-heading">The Internet Sector's Moment To Shine</h2>
<p>Roughly 79% of respondents anticipate market-cap-weighted Internet stocks to climb over 5% this year, outpacing expectations for the <strong>S&amp;P 500</strong>. </p>
<p>Advances in technology, return on AI investments, and upward earnings revisions are seen as key tailwinds pushing growth forward. </p>
<p>But it's not all smooth sailing—concerns over AI monetization, heavy capital expenditures, and valuation worries persist.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/news/25/01/42934302/supreme-court-hears-tiktok-case-google-donates-to-trump-inauguration-and-more-this-week-in-politics">Supreme Court Hears Tiktok Case, Google Donates To Trump Inauguration, And More: This Week In Politics</a></strong></p>
<h2 class="wp-block-heading">Alphabet Is Still King</h2>
<p>Investors overwhelmingly picked <strong>Alphabet Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) as the best-performing Mega Cap stock of 2025, with 43% favoring it over rivals. </p>
<p>Despite AI excitement, <strong>Meta Platforms Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) isn't getting much love, with 46% pegging it as the year's weakest link among the <a href="https://www.benzinga.com/topic/magnificent-seven">Magnificent Seven</a> stocks.</p>
<h2 class="wp-block-heading">Uber Takes The Wheel</h2>
<p><strong>Uber Technologies Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) emerged as the investor favorite among large-cap stocks, expected to outpace its peers in the ride-share and food delivery space.</p>
<p>Subscription models and online advertising were highlighted as the top-performing subsectors, with Alphabet dominating the ad race by a wide margin.</p>
<h2 class="wp-block-heading">GenAI: Big Buzz, Small Bucks?</h2>
<p>While 37% of respondents anticipate new Generative AI applications to make waves, only 6% foresee immediate revenue boosts. </p>
<p>Alphabet is seen as the biggest beneficiary of AI advancements, solidifying its position as the market leader.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/01/42904004/google-and-boeing-contribute-1m-each-to-trumps-inauguration-fund-youtube-to-livestream-event">Google And Boeing Contribute $1M Each To Trump&#8217;s Inauguration Fund: YouTube To Livestream Event</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Analyst Color

Long Ideas

Tech

GOOG

GOOGL

UBER

Investors Bet Big On Alphabet, Uber, GenAI In 2025: What JPMorgan Survey Reveals

<p>Citigroup  analyst Andrew Kaplowitz   maintains APi Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>) with a Buy and lowers the price target from $45 to $43.</p>


Citigroup Maintains Buy on APi Gr, Lowers Price Target to $43

<p>Citigroup  analyst Andrew Kaplowitz   maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $78 to $73.</p>


Citigroup Maintains Neutral on A.O. Smith, Lowers Price Target to $73

CF Industries Holdings shares are trading higher after Piper Sandler upgraded the stock from Underweight to Overweight and raised its price target from $79 to $105.

<p>TD Cowen  analyst Andrew Kilgerman   initiates coverage on Skyward Specialty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKWD#NASDAQ">SKWD</a>) with a Hold rating.</p>


Initiation

SKWD

TD Cowen Initiates Coverage On Skyward Specialty with Hold Rating

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Archer Aviation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ACHR, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Archer Aviation.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 80% bullish and 20%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $162,638, and 11 are calls, for a total amount of $1,003,826.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $3.0 to $17.0 for Archer Aviation over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Archer Aviation's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Archer Aviation's whale trades within a strike price range from $3.0 to $17.0 in the last 30 days. </p>
<h3>Archer Aviation 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736788527_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.55</td>
<td>$1.44</td>
<td>$1.55</td>
<td>$7.00</td>
<td>$575.2K</td>
<td>14.9K</td>
<td>4.4K</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.56</td>
<td>$7.00</td>
<td>$71.2K</td>
<td>13.3K</td>
<td>266</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.55</td>
<td>$1.54</td>
<td>$1.55</td>
<td>$7.00</td>
<td>$54.2K</td>
<td>14.9K</td>
<td>692</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.55</td>
<td>$1.54</td>
<td>$1.55</td>
<td>$7.00</td>
<td>$51.6K</td>
<td>14.9K</td>
<td>342</td>
</tr>
<tr>
<td>ACHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$2.19</td>
<td>$2.06</td>
<td>$2.06</td>
<td>$8.00</td>
<td>$51.0K</td>
<td>4.4K</td>
<td>317</td>
</tr>
</tbody>
</table>
</p>
<h3>About Archer Aviation</h3>
<p>Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.</p>
<p>Having examined the options trading patterns of Archer Aviation, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Archer Aviation's Current Market Status</h3>
<ul>
<li>With a volume of 15,216,400, the price of ACHR is down -9.78% at $8.09. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 42 days.</li>
</ul>
<h3>What The Experts Say On Archer Aviation</h3>
<p>4 market experts have recently issued ratings for this stock, with a consensus target price of $12.125.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Canaccord Genuity has decided to maintain their Buy rating on Archer Aviation, which currently sits at a price target of $14.<br />
&#x2A; Consistent in their evaluation, an analyst from HC Wainwright &amp; Co. keeps a Buy rating on Archer Aviation with a target price of $12.<br />
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Archer Aviation, which currently sits at a price target of $13.<br />
&#x2A; An analyst from JP Morgan has revised its rating downward to Neutral, adjusting the price target to $9. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Archer Aviation options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

ACHR

Looking At Archer Aviation's Recent Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Humana</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HUM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 20 uncommon options trades for Humana.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $264,753, and 13 are calls, for a total amount of $937,980.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $220.0 to $500.0 for Humana over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humana's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Humana's significant trades, within a strike price range of $220.0 to $500.0, over the past month.</p>
<h3>Humana 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736788522_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.2</td>
<td>$5.7</td>
<td>$6.2</td>
<td>$500.00</td>
<td>$308.7K</td>
<td>7.8K</td>
<td align="right">544</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$55.2</td>
<td>$53.2</td>
<td>$54.5</td>
<td>$260.00</td>
<td>$70.8K</td>
<td>25</td>
<td align="right">14</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$50.7</td>
<td>$44.7</td>
<td>$47.0</td>
<td>$300.00</td>
<td>$70.5K</td>
<td>143</td>
<td align="right">15</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.5</td>
<td>$9.8</td>
<td>$11.5</td>
<td>$280.00</td>
<td>$64.4K</td>
<td>1.7K</td>
<td align="right">147</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$82.6</td>
<td>$80.3</td>
<td>$80.3</td>
<td>$220.00</td>
<td>$64.2K</td>
<td>27</td>
<td align="right">8</td>
</tr>
</tbody>
</table>
</p>
<h3>About Humana</h3>
<p>Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.</p>
<p>Following our analysis of the options activities associated with Humana, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Humana</h3>
<ul>
<li>With a trading volume of 975,075, the price of HUM is up by 7.0%, reaching $287.88.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 29 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Humana</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $295.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Hold rating for Humana, targeting a price of $290.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Humana, which currently sits at a price target of $301. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Humana options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Market Whales and Their Recent Bets on HUM Options

<p>Deep-pocketed investors have adopted a bullish approach towards Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SCHW usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Charles Schwab. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 33% bearish. Among these notable options, 4 are puts, totaling $383,469, and 8 are calls, amounting to $961,357.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $52.5 to $100.0 for Charles Schwab over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Charles Schwab's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Charles Schwab's substantial trades, within a strike price spectrum from $52.5 to $100.0 over the preceding 30 days.</p>
<h3>Charles Schwab Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736788516_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SCHW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.4</td>
<td>$3.3</td>
<td>$3.37</td>
<td>$72.50</td>
<td>$338.7K</td>
<td align="right">842</td>
<td>1.0K</td>
</tr>
<tr>
<td>SCHW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.4</td>
<td>$72.50</td>
<td>$209.2K</td>
<td align="right">842</td>
<td>2.6K</td>
</tr>
<tr>
<td>SCHW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$1.81</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$71.00</td>
<td>$150.5K</td>
<td align="right">85</td>
<td>1.1K</td>
</tr>
<tr>
<td>SCHW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.4</td>
<td>$72.50</td>
<td>$123.9K</td>
<td align="right">842</td>
<td>2.0K</td>
</tr>
<tr>
<td>SCHW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.55</td>
<td>$5.45</td>
<td>$5.45</td>
<td>$67.50</td>
<td>$123.7K</td>
<td align="right">612</td>
<td>228</td>
</tr>
</tbody>
</table>
</p>
<h3>About Charles Schwab</h3>
<p>Charles Schwab operates in brokerage, wealth management, banking, and asset management. It runs a large network of brick-and-mortar brokerage branch offices and a well-established online investing website, and it has mobile trading capabilities. It also operates a bank and a proprietary asset-management business and offers services to independent investment advisors. Schwab is among the largest firms in the investment business, with over $9 trillion of client assets at the end of September 2024. Nearly all of its revenue is from the United States.</p>
<p>Having examined the options trading patterns of Charles Schwab, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Charles Schwab Standing Right Now?</h3>
<ul>
<li>With a volume of 1,610,832, the price of SCHW is down -0.99% at $72.05. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>Expert Opinions on Charles Schwab</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $84.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Charles Schwab, targeting a price of $70.<br />
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Charles Schwab with a target price of $80.<br />
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Charles Schwab, maintaining a target price of $93.<br />
&#x2A; Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Outperform rating for Charles Schwab, targeting a price of $93. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Charles Schwab, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


SCHW

This Is What Whales Are Betting On Charles Schwab

AXSM

Axsome Therapeutics shares are trading higher after the company reported preliminary Q4 and FY2024 net product revenue. Additionally, Truist Securities raised its price target on the stock from $150 to $180 while maintaining a Buy rating.

Comments

CD Intl Enterprises

News

Latest news for CD Intl Enterprises (OTC:CDIIQ) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga